Page last updated: 2024-10-31

midodrine and Left Ventricular Hypertrophy

midodrine has been researched along with Left Ventricular Hypertrophy in 2 studies

Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Montagnac, R1
Clavel, P1
Delhotal-Landes, B1
Flouvat, B1
Poulain, S1
Schillinger, F1
Perazella, MA1

Reviews

1 review available for midodrine and Left Ventricular Hypertrophy

ArticleYear
Pharmacologic options available to treat symptomatic intradialytic hypotension.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001, Volume: 38, Issue:4 Suppl 4

    Topics: Adrenergic Agents; Autonomic Nervous System; Caffeine; Carnitine; Ephedrine; Fludrocortisone; Hemodi

2001

Other Studies

1 other study available for midodrine and Left Ventricular Hypertrophy

ArticleYear
[Midodrine (Gutron) treatment of permanent arterial hypotension in a chronic hemodialysis patient].
    Nephrologie, 2000, Volume: 21, Issue:4

    Topics: Adrenergic alpha-Agonists; Chronic Disease; Heart Failure; Humans; Hypertrophy, Left Ventricular; Hy

2000